Study of treatment outcome of tuberculosis among HIV co-infected patients: a cross sectional study in Aurangabad city, Maharashtra

Authors

  • Prashant D. Warkari Department of Community Medicine, MGM Medical College, Aurangabad, Maharashtra, India http://orcid.org/0000-0002-8560-3905
  • Mahavir P. Nakel Department of Community Medicine, MGM Medical College, Aurangabad, Maharashtra, India
  • Swati M. Mahajan Department of Community Medicine, MGM Medical College, Aurangabad, Maharashtra, India
  • Sangita A. Adchitre Department of Community Medicine, MGM Medical College, Aurangabad, Maharashtra, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20175163

Keywords:

Treatment outcome, Tuberculosis, HIV, ART, CPT

Abstract

Background: Tuberculosis is the most common presenting illness among people living with HIV, including those who are taking anti-retroviral treatment. There were an estimated 1.2 million HIV positive new TB cases globally in 2014. Around 74% of these infected people live in sub-Saharan Africa. Aim and objectives were to study the treatment outcome of tuberculosis among HIV co-infected patients; to assess the outcome of TB treatment in TB patients with respect to their HIV status and to study the underlying factors influencing the outcome rates.

Methods: A descriptive cross-sectional study was designed and conducted in Municipal Corporation area, Aurangabad. For this study, HIV co-infected patients registered at city Tuberculosis Centre, Aurangabad were noted and thus information only on TB-HIV status of patients was collected.

Results: In this study majority of the study participants were in the age group between 35 and 49 years (45.98%); which is in the reproductive age group. HIV-TB co-infected in this region was mostly males (60.92%).

Conclusions: Important conclusion of the study is that very few patients got cured off TB among TB-HIV co-infected patients. One of the reasons could be immunosuppression of HIV patients make them vulnerable for getting active TB and its rapid progression. All the rates i.e. death, default & transfer rate are all above the standard rate i.e. 5% as per RNTCP guidelines. 

Author Biography

Prashant D. Warkari, Department of Community Medicine, MGM Medical College, Aurangabad, Maharashtra, India

tutor,dept.of community medicine,mgm medical college aurangabad

References

Global Tuberculosis Control 2016, WHO, Geneva, 2016, www.who.int/tb/publications/global_ report/en. Accessed 13 November 2017.

International Classification of Diseases (ICD), WHO, Geneva, 2010 www.who.int/classifications/ icd/en. Accessed 13 November 2017.

UNAIDS Report on the Global AIDS Epidemic 2012: UNAIDS, 2012. www.unaids.org/en/ resources/campaigns/20121120_globalreport 2012. Accessed 13 November 2017.

Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a public health approach 2010 revision, WHO, Geneva, 2010. www.who.int/hiv/topics/treatment/en/index. html. Accessed 13 November 2017.

The Global Plan to Stop TB. WHO, Geneva, 2011. www.stoptb.org/global/plan. Accessed 13 November 2017.

Global Tuberculosis control 2014. WHO, Geneva, 2014,www.who.int/tb/publications/global report. Accessed 13 November 2017.

Chaovavanich A, Chottanapand S, Manosuthi W, Sungkanuparph S, Thongyen S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr. 2006;43:42–6.

Dagnra AY, Adjoh K, Tchaptchet Heunda S, Patassi AA, Sadzo D, Hetsu F, et al. Prevalence of HIV-TB co-infection and impact of HIV infection on pulmonary tuberculosis outcome in Togo. Bull Soc Pathol Exot. Bull Soc Pathol Exot. 2011;104(5):342-6.

Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis (Section A7) New Delhi, India: National AIDS Control Organization; 2007.

Kumarasamy N, Vallabhaneni S, Flanigan TP, Mayer KH, Solomon S. Clinical profile of HIV in India. Indian J Med Res. 2005;121:377–94.

Sharma SK, Mohan A, Kadhiravan T. HIV-TB coinfection: Epidemiology, diagnosis and management. Indian J Med Res. 2005;121:550–67.

Deivanayagam CN, Rajasekaran S, Senthilnathan V, Krishnarajasekhar R, Raja K, Chandrasekar C, et al. Clinicoradiological spectrum of tuberculosis among HIV sero-positives a Tambaram study. Indian J Tuber 2001;48:123–7.

Ahmad Z, Shameem M. Manifestations of Tuberculosis in HIV Infected Patients. J Indian Acad Clin Med. 2005;6:302–5.

Kebede D, Mitike G, Yeneneh H. HIV Infection and Antituberculosis Drug Resistance among Pulmonary Tuberculosis Patients in Harar Tuberculosis Center, Ethiopia. East African Med. J 1997;74:154–20.

World Health Organization. Treatment of tuberculosis Guidelines. 4th edition.2010.

Ali SA, Mavundla TR, Fantu R, Awoke T. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study. BMC Infec Dis. 2016;16(1):640.

Downloads

Published

2017-11-23

How to Cite

Warkari, P. D., Nakel, M. P., Mahajan, S. M., & Adchitre, S. A. (2017). Study of treatment outcome of tuberculosis among HIV co-infected patients: a cross sectional study in Aurangabad city, Maharashtra. International Journal Of Community Medicine And Public Health, 4(12), 4466–4471. https://doi.org/10.18203/2394-6040.ijcmph20175163

Issue

Section

Original Research Articles